A Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of DWC202206 and DWC202207 in Patients With Concomitant Hypertension and Hyperlipidemia

NCT05643508 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

214

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension
Hyperlipidemias

Interventions

DRUG: (D) DWC202206
DRUG: (D) DWC202207
DRUG: (P) DWC202206
DRUG: (P) DWC202207

Sponsor

Daewoong Pharmaceutical Co. LTD.